WORLD AIDS DAY

	Mr. Ziren Xiao ( Director of China Medicinal Biotech Association, China) gave a speech.
	Dr. Xiaodan Mei ( President of WHTS, Director of BIT Institute of Drug Discovery) hosted the opening ceremony.
	Dr. Jason Zhou (Chairman, FusoGen Pharmaceuticals, Inc., China ) gave a speech.
	Delivering greeting by Dr. Richard J. Roberts (The Nobel Prize in Physiology or Medicine 1993).
	Opening ceremony
	More than 800 people participated in the Opening Ceremony

Nobel and Keynote Forum

Place: International Conference Room, 2F , Tianjin Tianbao International Hotel
Time: 10:00-11:30, Dec. 1, 2006

Photos

Name & Organization

Chair:

Dr. Gao, G.F., Director - General & Professor, The Institute of Microbiology, Chinese Academy of Sciences (IMCAS), China

	Title: Women and HIV/AIDS: Risks, Rights, Resouces Dr. Nafis Sadik, UN Special Envoy for HIV/AIDS in Asia and Pacific, and former UNFPA Executive Director
	Title: Prospects in AIDS Research 2006 Prof. Luc Montagnier, Pioneer in HIV/AIDS Disvoeries, co-founder and president of the World Foundation for AIDS Research and Prevention
	Title: Roles of the ubiquitin system in health and disease Dr. Avram Hershko, Nobel Prize Laureate in Chemistry in 2004
	Title: Why do we not have a vaccine against HIV or Tuberculosis yet? Dr. Rulf M. Zinkernagel, 1996 Nobel Prize Laureate in Physiology or Medicine
	More than 800 people participated in the Nobel and Keynote Forum

Technology Session

Session One: Current Advances in HIV Vaccine Development and Update on HIV Therapeutic Vaccine

Place: VIP Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 13:30-17:00, Dec. 1, 2006

Chair	Name & Organization
Session Chair	Dr. Opendra Narayan, Chairman of Department of Microbiology, Molecular Genetics & Immunology,University of Kansas Medical Center
Co-Chair	Dr. Shan Lu, Director, New type Vaccine Research, UMass Med School, USA

Photos	Name & Organization
	Title: Superior Interferon and its Anti-HIV Function Dr. Xinyuan Liu, Professor, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
	Title: Creation of HIV-1 Vaccine Candidates Using MolecularBreeding? Directed Molecular Evolution Dr. X. Sean Du, Department of Infectious Diseases, Maxygen, Inc, USA
	Title:Use of Macaque Model to Study Pathogenesis and Vaccine Development Against HIV Dr. Opendra Narayan, Chairman of Department of Microbiology, Molecular Genetics & Immunology, University of Kansas Medical Center
	Title: An important progress on HIV vaccine development Dr. Shan Lu, Director, New type Vaccine Research, UMass Med School, USA
	Title: DEVELOPMENT OF VACCINES AGAINST HIV/AIDS: A CHALLENGE FOR SCIENCE AND SOCIETY Dr. Hans Wolf, Director, Institute for Medical Microbiology and Hygiene, University of Regensburg, Germany
No Photo	Title: A peptide-based vaccine that induces cross-clade reactivity in Macaques Dr. Francisco Diaz-Mitoma, Professor and Chief, Division of Virology, University of Ottawa
	Title:Preclinical evaluation of the safety and efficacy of an HIV-1 envelope peptide-cocktail vaccine in macaque models Dr. K. Jagannadha Sastry, The University of Texas MD Anderson Cancer Center, Houston, USA
	Title: Novel HIV Bacterial Vectored Vaccines Dr. Jerald Sadoff, CEO, Aeras Global TB Vaccine Foundation, USA
No Photo	Title: The development of Clinical trail on HIV treatment Dr. Chengxiang Dai, CMO, Beijing Venturepharm CRO Service Group, China

Session Two: HIV Reverse Transcriptase, Protease, Integrase Inhibitors and Fusion Inhibitors for Therapy

Place: Grand Ball Room, 2F, Tianjin Tianbao International Hotel
Time: 13:30-17:00, Dec. 1, 2006

Photos	Name & Organization
	Title: Novel HIV therapeutic strategies targeting viral entry Dr. K. Jagannadha Sastry, The University of Texas MD Anderson Cancer Center, Houston, USA
	Dr. Jason Zhou, Chairman, FusoGen Pharmaceuticals, Inc., China
	Title: HIV-1 Reverse Transcriptase Dimerization as a Drug Target Dr. Gilda Tachedjian, Senior Burnet Fellow, NHMRC RD Wright Fellow, ASMR Director Head, Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public , Australia
	Title: Design, synthesis and biological activities of quinolinonyl derivatives as inhibitors of HIV-1 integrase Dr. Roberto Di Santo, Associated Professor in Medicinal Chemistry, Università degli Studi di Roma La Sapienza, Italy
	Title: The mode of action of HIV fusion inhibitors at the molecular level Dr. Miguel A R B Castanho, Department of Chemistry and Biochemistry, University of Lisbon, Portugal
	Title: Genomic variability of HIV-1 and resistance to antiretroviral drugs Dr. HJ Fleury, Professor of Virology and head of the Department of Virology and Immunology of the University Hospital of Bordeaux, France
	Title: Drug design of anti-HIV Dr. Wang Cunxin, Professor, Vice Director, College of life science & Bioengineering Beijing University of Technology
	Title: Pharmacology of antiretroviral drugs Dr. Marta Boffito, Associate Director of PK Research, St. Stephen's Centre, Chelsea and Westminster hospital, UK
	Title: Carbohydrate-Binding Agents (CBA) as Novel Entry Inhibitors of HIV, A new therapeutic concept Dr. Jan balzarini, Professor, Institue for Medical Research, Katholieke Universiteit Leuven
	Title:Substrate Specificity in HIV-1 Protease by a Biased Sequence Search Method *Dr. Turkan Haliloglu*, Polymer Research Center and Chemical Engineering Department, Bogazici University, Bebek, Istanbul, Turkey
	Title: Dual Inhibitors of HIV-1 Entry and Integration Dr. Sylvia Lee-Huang, Department of Biochemistry, New York University School of Medicine, USA

Session Three: Optimize & Integrate Investing for Our Future-Global Fund to Fight AIDS, Policy & Regulation Understanding

Place: No. 1 Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 13:30-17:00, Dec. 1, 2006

Chair	Name & Organization
Session Chair	Dr. Nafis Sadik, UN Special Envoy for HIV/AIDS in Asia and Pacific, and former UNFPA Executive Director
Co-Chair	Dr. Helene Rossert-Blavier, Former Vice-Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM)

Photos	Name & Organization
	Title: Optimize and Integrate Investing for Our Future - Global Fund to Fights AIDS, Policy & Regulation Understanding Dr. Nafis Sadik, UN Special Envoy for HIV/AIDS in Asia and Pacific, and former UNFPA Executive Director
	Title: Effective and sustainable programs to fight HIV/AIDS pandemic will require a thorough understanding of partnerships between governments and NGOs Dr. Helene Rossert-Blavier, Former Vice-Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM)
	Title:The shortage and limmitation of Chinese current policy to fight HIV/AIDS based on the increasing cases of sexual contact among the all kind HIV/AIDS casses lately Dr. Jiatong Zhuo, Deputy Director, Guangxi Provincial CDC, China
	Title: The Role of Microfinance in Fighting HIV/AIDS: The Case of Opportunity International's OVC Project in Three African Countries Dr. Makonen Getu, Director for Strategic Alliances/OVC Project Manager, Opportunity International, United States
	Title: Disseminating a schools-based, behaviourally effective Sex and Relationships Education programme, from research to service in the UK Dr. John Rees, Exeter University, UK, APAUSE Programme Manager
	Title: Monitoring HIV Risk Behaviours among Adolescents in School Populations: HIV Risk among Asian Youth in Western Canada Dr. Elizabeth Saewyc, Associate Professor, University of British Columbia School of Nursing, Canada
	Title: PREVENTION OF HIV EPIDEMIC IN BANGLADESH : AN EXPERIENCE OF WORKING WITH LAW ENFORCING AGENCIES AND UNFPA Dr. Zaman Ara, National Professional Project Personnel (NPPP) United Nations Population Fund (UNFPA) Bangladesh Country Office
No Photo	Title: Sustainable HIV /AIDS Programme Financing: Private Sector As Gap and Opportunity Dr. Adeyemi Egbeleke, Centre for Africa Development Operations Coordination (CADOC)

Session Four: Specific Expertise In HIV-Related Basic Science And Clinical Research-Immunology/Etiology—Ⅰ

Place: VIP Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 08:30-12:00, Dec. 2, 2006

Chair	Name & Organization
Session Chair	*Dr. Panayiotis Zavos*, Director, Andrology Institute of America, USA
Co-Chair	Dr. Doris B. Tse, Director, Flow Cytometry Core, Center for AIDS Research, New York University School of Medicine, USA

Photos	Name & Organization
	Title:Retroviral Integration and Assembly: Targets for Inhibition Dr. Iva Pichova, Institute of Organic Chemistry and Biochemistry, Czech Republic
	Title: Use of Stem Cells in Battle Against AIDS Dr. Panayiotis Zavos, Director, Andrology Institute of America, USA
	Title: HIV-1 Vpr as a determinant of cytopathicity in vivo Dr. Vicente Planelles, Associate Professor of Pathology, University of Utah School of Medicine
	Title: Host Genetics and HIV-1 resistance Dr. Kalpana Luthra, Associate Professor, Department of Biochemistry, All India Insititute of Medical sciences, India
	Title: An 85 amino acid segment of the GB Virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T-cells Dr. Jinhua XIANG, The university of Iowa & VA, USA
	Title: CCR5 expression in HIV Resistance and Co-infection Dr. Doris B. Tse, Director, Flow Cytometry Core, Center for AIDS Research, New York University School of Medicine, USA
	Title: Molecular Basis for Opioids and AIDS Virus Interactions Using Simian AIDS as an animal model Dr. RONALD Y. CHUANG, Dept. of Med Pharmacology & Toxicology School of Medicine, University of California
No Photo	*Title: AIDS-associated GuillainBarre Syndrome and Elevated Anti-Sulfatide Antibodies Dr. Nizar Souayah**, Assistant Professor of Neurology, Director of EMG LAB & Peripheral Neuropathy Center, New Jersey Medical School

Session Five: International HIV/AIDS Programs Cooperation and New Technologies/Products Showcase

Place: Grand Ball Room, 2F, Tianjin Tianbao International Hotel
Time: 08:30-12:00, Dec. 2, 2006

Chair	Name & Organization
Session Chair	Dr. Roger Hershline, CEO, Global Humanceuticals Inc., USA
Co-Chair	Dr. Wang Peng, Director, Department of International Cooperation, China Preventive Medicine Association (CPMA)

Photos	Name & Organization
	Title: New Therapeutic Strategies Aimed at Eradicating HIV Infection Dr. Luc Montagnier, Professor, Center for Molecular and Cellular Biology, Queens College, New York; Pasteur Institute, Paris; and World Foundation AIDS Research and Prevention
No Photo	Title: The status of ART scale-up in Zambia: Challenges and successes Dr. Richard Hughes, Country Director, JHPIEGO Zambia
	Title: Potential Strategies for HIV-1 Eradication Exploiting the Effects of Chloroquine Dr. Andrea Savarino, Department of Infectious, Parasitic and Immune-mediated Diseases Istituto Superiore di Sanit, Italy
	Title: The enhancement of the efficacy of HIV vaccines and AIDS therapies by Pheroid technology Ms. Anne Grobler, Dept of Pharmaceutics, North-West University, South Africa
	Title: Using Appropriate Technology, Systems Approaches, and Public-Private Partnerships to Develop Large-scale ARV Treatment Programs: A Case Study from South Africa Dr. John Sargent, President & COO, BroadReach Healthcare, LLC, USA
No Photo	Title: Prices Paid vs. Prices Announced: Examining Prices of Antiretrovirals (ARVs) in China Dr. Elodie Jambert, Pharmacist, Medecins sans Frontieres(MSF), Beijing
No Photo	Title: The Humanceuticl Approach Dr. Roger Hershline, CEO, Global Humanceuticals Inc., USA
Dr. Ralf Panse Dr. Wang Peng	Title: Chinese-German E-Learning Programme on HIV/AIDS Prevention and Control Concept – Content - Didactics Dr. Ralf Panse, Vice-Head Health Division, InWEnt - Internationale Weiterbildung und Entwicklung gGmbH Dr. Wang Peng, Director, Department of International Cooperation, China Preventive Medicine Association (CPMA)
No Photo	Title: From Lab. Bench to People’s Bedside: Technology Transfer in National Institutes of Health Dr. Sally H. Hu, Technology Licensing Specialist, Infectious Disease & Medical Engineering Group, Office of Technology Transfer, National Institutes of Health, USA
	Title: THE LAKE VICTORIA BASIN HIV/AIDS INTEGRATED PROJECT Mr. John N Mwanga, Executive Director, Action Photoss FAMILY Care, Kenya

Session Six: Proficient Medicinal Chemistry for Better New Anti-HIV Drugs and CADD

Place: No. 1 Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 08:30-12:00, Dec. 2, 2006

Chair	Name & Organization
Session Chair	*Dr. Shibo Jiang,* Head of Viral Immunology Laboratory, New York Blood Center, USA
Co-Chair	Dr. Lan Xie, Professor, Beijing Institute of Pharmacology & Toxicology, China

Photos	Name & Organization
	Title: Rational design of small molecule HIV-1 entry inhibitors targeting gp41 Dr. Shibo Jiang, Head of Viral Immunology Laboratory, New York Blood Center, USA
	Title: Discovery of Novel HIV-1 Inhibitors Dr. Yun He, Associate Director Medicinal Chemistry Genomics Institute of the Novartis Research Foundation (GNF)
	Title: Targeting the HIV-1 Genome: RNA Structure-Based Drug Discovery Dr. Thomas L. James, Department of Pharmaceutical Chemistry, University of California, San Francisco, USA
	Title: A Novel Kind of HIV-1 NNRTIs: From Natural Product Suksdorfin to Preclinical Candidates 3’,4’-Di-O-(S)-camphanoyl-(+)-cis-khellactone Analogs (DCKs) Dr. Lan Xie, Professor, Beijing Institute of Pharmacology & Toxicology, China
	Title: Interaction of HIV-1 integrase and cellular factor and their functional roles during viral replication Dr. Xiao-jian Yao, University of Manitoba, Canada
	Title: The Discovery of Vicriviroc (Sch 417690), a potent CCR5 Antagonist for Treating HIV Infection Dr. Jayaram Tagat, Research Fellow, Medicinal Chemistry, Schering-Plough Research Institute, USA
No Photo	Title: Design, Synthesis of Novel Substituted Heterothiadiazines and Heterothiatriazines as Potent HIV-1 NNRTIs Dr. Xinyong Liu, Institute of Medicinal Chemistry, School of Pharmaceutical Science, Shandong University, China
	Title: Discovery of Anti-HIV Drugs Using Computer Aided Drug Design Tool Dr. Dongqing Wei, College of Life Science and Biotechnology, Shanghai Jiaotong University, China
	Title: Peptide Reagent Design Based on Physical and Chemical Properties of Amino Acid Residues for HIV Peptide Fusion Inhibitors Dr. Qishi Du, Institute of Bioinformatics and Drug Discovery, Tianjin Normal University, China
	Title: Potential HIV-1 Integrase Inhibitors: Molecular Structures Of Selected Quinoline Derivatives Dr. Katarzyna Majerz-Maniecka, Robert Musiol, Barbara J. Oleksyn, Jean-Francois Mouscadet, Marc Le Bret, Jaroslaw Polanski

Session Seven: Microbicides: A Powerful New Prevention Tool in the fight against HIV/AIDS

Place: Grand Ball Room, 2F, Tianjin Tianbao International Hotel
Time: 13:30-17:00, Dec. 2, 2006

Chair	Name & Organization
Session Chair	Dr. Alan Stone, Chair of the International Working Group on Microbicides, UK
Co-Chair	Dr. Alexander M. Cole, Associate Professor, Dept. of Molecular Biology and Microbiology, University of Central Florida, USA

Photos	Name & Organization
	Title: Key challenges in microbicide development Dr. Alan Stone, Chair of the International Working Group on Microbicides, UK
	Title: the potential topical application of a new class of tight-binding NNRTIs Dr. Paolo La Colla, University of Cagliari , Italy
	Title: Development of Retrocyclin as a Topical Microbicide Dr. Alexander M. Cole, Associate Professor, Dept. of Molecular Biology and Microbiology, University of Central Florida, USA
	Title: The effects of Fangxin-KONRAPO (microbiocide) in the prevention of the sexual transmitted diseases and human reproducetive health Dr. Wu Yan-wan, NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING, WHO COLLABORATING CENTRE FOR RESEARCH IN HUMAN REPRODUCTION
	Title: Development of anti-HIV microbicides for preventing sexual transmission of HIV in China Dr. Shibo Jiang, Head of Viral Immunology Laboratory, New York Blood Center, USA
	Title: Microbicides and Cervical Barriers: BufferGel and Duet Dr. Richard A. Cone, Professor Biophysics, Johns Hopkins University
No Photo	Title: The EMPRO and the Stellenbosch University contribution Prof. Pieter van der Bijl, Head of Pharmacology, Stellenbosch University, South Africa

Session Eight: The Global Strategies and Effectiveness for HIV/AIDS Prevention and Control

Place: VIP Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 13:30-17:00, Dec. 2, 2006

Chair	Name & Organization
Session Chair	Dr. Jane T. Bertrand, Director, Center for Communication Programs, Johns Hopkins Bloomberg School of Public Health, USA
Co-Chair	*Dr. Mbopi-Keou FX*, University of Yaounde I Cameroon& Ministry of Public Health, Cameroon

Photos	Name & Organization
	Title: The Union model to deliver Integrated HIV care for Tuberculosis patients? Dr. Philippe Clevenbergh, International Union Against Tuberculosis, France
	Title : Synergistic interactions between genital herpes infection and HIV in Africa : opportunities for public health interventions Dr. Mbopi-Keou FX , University of Yaounde I Cameroon& Ministry of Public Health, Cameroon
	Title: Social consequences of HIV-positive women's participation in prevention of mother-to-child transmission programmes *Dr. Magnhild Eide*, University of Oslo. Norway
	Title: TB and HIV co-infection in Eastern-Europe, Collaboration between TB and HIV/AIDS programmes at national level Dr. Manfred Danilovits, Head, Department of Tuberculosis, Tartu University Clinics, Lung Clinic Estonian National Tuberculosis Program, coordinator
	Title: Heightened Vulnerability to HIV-risk among Women and Older African Americans Dr. Sharon D. Johnson, Associate Professor, Department of Social Work, University of Missouri - St. Louis, USA
	Title: Strategies for HIV Prevention in China Ms. Mariam Khan, Deputy Representative, UNFPA China
	Title: HIV/AIDS AND DEVELOPMENT: THE DEVELOPING COUTRIES PERSPECTIVE Dr. Patrick A. Orege, National AIDS Control Council, Kenya
	Title: The Role of Communication in the Prevention and Treatment of HIV/AIDS Dr. Jane T. Bertrand, Director, Center for Communication Programs, Johns Hopkins Bloomberg School of Public Health, USA
	Title: Is Administration of HAART Therapy to Mothers in PMTCT Programs Cost-Effective? The results of the DREAM program. Dr. Stefano Orlando, Community of Sant'Egidio– DREAM program, Italy

Session Nine: Research on HIV Clinic-Testing and Diagnosis

Place: No. 1 Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 13:30-17:00, Dec. 2, 2006

Chair	Name & Organization
Session Chair	Dr. Freddy Karup Pedersen, Head of the University Clinic of Pediatrics, Copenhagen , Denmark ; Member of The Standing Commission of The International Red Cross
Co-Chair	Dr. Mobeen H. Rathore, Professor and Assistant Chairman, Chief, Pediatric Infectious Diseases, Wolfson Children's Hospital and University of Florida Health Science Center/Jacksonville

Photos	Name & Organization
	Title: HIV Dementia: A Global Perspective Dr. Ned Sacktor, Associate Professor of Neurology, Johns Hopkins University School of Medicine, USA
	Title: Experiences from treatment with ARV drugs in a setting with less developed health infrastructure Dr. Freddy Karup Pedersen, Head of the University Clinic of Pediatrics, Copenhagen, Denmark; Member of The Standing Commission of The International Red Cross
	Title: The effectiveness of HIV testing and counselling and needle exchange programs to prevent HIV among IDUs; do we need more knowledge? Dr. Ellen J. Amundsen, Norwegian Institute for Alcohol and Drug Research
	Title: Access to HIV care for Women and Adolescent Dr. Mobeen H. Rathore, Professor and Assistant Chairman, Chief, Pediatric Infectious Diseases, Wolfson Children's Hospital and University of Florida Health Science Center/Jacksonville
	Title: Microcapillary Flow Cytometer Guava PCATM Lowers the Cost of AIDS Diagnosis and Treatment Monitoring with the Easy CD4TM Assay System Dr. Ramakrishna Machiraju, Guava Technologie, USA
	Title: Marker proposed for pre-screening of early HIV infection, determined by simple schematic 1-min face drawing test of "Neolithic Face" Configurations Dr. Anneliese Alma Pontius, Associate Clinical Professor of Psychiatry (ret,) Harvard Medical School, Boston, MA/USA
	Title: The Senegalese Model for scaling up access to antiretroviral drugs: the mentoring approach Dr. SOW Papa Salif, Department of Infectious Diseases, Dakar University teaching Hospital
	Title: Rapid and Synchronous Detection of HIV Type I and II Antibodies by Using Dot Immuno-Gold Filtration Assay Dr. Yefu Wang, Professor, Department of Biotechnology, College of Life Science, Wuhan University, China

Session Ten: Development of Natural Products and TCM as Anti-HIV Drugs

Place: VIP Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 08:30-12:00, Dec. 3, 2006

Chair	Name & Organization
Session Chair	Mr. Sayyed Ashraf, CEO, Hootone Remedies, India
Co-Chair	Dr. Chin Ho Chen, Center for AIDS Research, Duke University Medical Center, USA

Photos	Name & Organization
	Title: HIGHLY EFFECTIVE UNANI MEDICINE HOO-IMM PLUS FOR THE HIV/ AIDS PATIENTS Mr. Sayyed Ashraf, CEO, Hootone Remedies, India
	Tittle: Actinohivin, a promising anti-HIV protein of microbial origin Dr. Haruo Tanaka, Director of The Kitasato Institute, Japan
	Title: Marine Organisms as a source of anti-HIV activity Dr. Debashis Mitra, National Centre for Cell Science, Pune University Campus, India
	Title: Approach to Development of Safe entry inhibiting antivirals from natural sources Dr. Girish J. Kotwal, Professor Division of Medical Virology, University of Cape Town, Cape Town, South Africa
	Title: Semi-synthesis of potent anti-HIV natural products with novel mechanisms of action Dr. Chin Ho Chen, Center for AIDS Research, Duke University Medical Center, USA
No Photo	Title：Sulfated NF1 Polysaccharide--A new drug for Anti-HIV (AIDS) Professor Xi Chen, Life science school, Nanjing University, China

Session Eleven: Specific Expertise In HIV-Related Basic Science And Clinical Research-Immunology/Etiology—Ⅱ

Place: Grand Ball Room, 2F, Tianjin Tianbao International Hotel
Time: 08:30-12:00, Dec. 3, 2006

Chair	Name & Organization
Session Chair	Dr. Carlos Trabulo, Boehringer Ingelheim, Portugal
Co-Chair	Dr. Margalit Lorber, Rambam Medical Center, Israel

Photos	Name & Organization
	Title: Covariation Analysis of the Amino Acid Sequence of HIV-1 Subtype B Protease and its Gag-Pol Cleavage Sites Dr. Viktor Müller, Eotvos Lorand University, Institute of Biology, Hungary
	Title: Sperm washing in HIV Discordant Couples - a mean of risk-reduction in HIV discordant couples wishing to have a child Dr. Margalit Lorber, Rambam Medical Center, Israel
	Title: Opportunistic infections: What do we learn from Southeast Asia? Dr. Veeranoot *Nissapatorn*, Department of Parasitology, University of Malaya, Malaya
	Title: THE INVOLVEMENT OF THE BLOOD-BRAIN BARRIER IN HIV-1 INFECTION Dr. Michal Toborek, Molecular Neuroscience and Vascular Biology Laboratory, Department of Surgery, University of Kentucky Medical Center, USA
	Title：Neuropsychiatric effects of HIV Dr. Igor Grant, University of California, San Diego, USA
	Title: Depression and Suicidality in HIV/AIDS in China Dr. Hua Jin, Assistant Clinical Professor, University of California, San Diego, USA

Session Twelve: Current Research and Perspectives of anti-HIV Antibodies

Place: No. 1 Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 08:30-10:00, Dec. 3, 2006

Chair	Name & Organization
Session Chair	Dr. Miguel E. Quinones-Mateu, Cleveland Clinic Foundation, Lerner Research Institute
Co-Chair	Dr. Shilpa J. Buch, Dept. Molecular & Integrative Physiology Kansas University Medical Center, USA

Photos	Name & Organization
	Title: Condom Use for HIV prevention: Lessons from South Africa Dr. Pranitha Maharaj, School of Development Studies, University of KwaZulu-Natal, Durban, South Africa
	Title: Therapy of SHIV-Infected Macaques with Antisense DNA of Interleukin-4 Dr. Shilpa J. Buch, Dept. Molecular & Integrative Physiology Kansas University Medical Center, USA

Session Thirteen: New Strategies and Technologies to Solve HIV Drug Resistance and Treatment

Place: No. 1 Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 10:00-12:00, Dec. 3, 2006

Chair	Name & Organization
Session Chair	Dr. Miguel E. Quinones-Mateu, Diagnostic Hybrids, Inc., Athens, OH, USA
Co-Chair	Dr. Shilpa J. Buch, Dept. Molecular & Integrative Physiology Kansas University Medical Center, USA

Photos	Name & Organization
	Title: The preliminary impression of Lamivudine/Zidovudine (3TC/ZDV) plus Efavirenz (EFV)Treatment in China Dr. Yunzhen Cao, Professor, Clinical Director, The AIDS Research Center, CAMS, PUMC, China
	Title: Using EGFP- and DsRed2-tagged viruses to study HIV-1 drug resistance, replicative fitness, and tropism Dr. Miguel E. Quinones-Mateu, Diagnostic Hybrids, Inc., Athens, OH, USA
	Title: Diminished Anti-retroviral Therapy (ART) Exposure and improved Virological and Immune outcomes with Therapeutic Vaccination after ART intensification, GM-CSF and Hydroxyurea in Chronic HIV disease: a 5%-year pilot trial (CTN 140 study) Dr. Emil Toma, MD, DSc, FRCP(C), Department of Microbiology & Immunology-University of Montreal, Canada
	Title: HIV-1 fitness impact factors within its genome Dr. Yong Gao, Division of Infectious Diseases, Center for AIDS Research, Case Western Reserve University

Session Fourteen: Research on HIV Clinic-The Research/ Treatment/ Prognosis on HIV and Complication In HIV-Infected Patients

Place: VIP Meeting Room, 2F, Tianjin Tianbao International Hotel
Time: 13:30-17:00, Dec. 3, 2006

Chair	Name & Organization
Session Chair	Dr. Anders Vahlne, Professor & Head, Division of Clinical Virology, Karolinska Institutet, Sweden
Co-Chair	Dr. Giorgio Barbarini, Chief of Outpatients' Structure, Department of Infectious and Tropical Diseases, Foundation IRCCS San Matteo University of Pavia, Italy

Photos	Name & Organization
	Title: Hiv Infection And The Cardiovascular System Dr. Giorgio Barbarini, Chief of Outpatients' Structure, Department of Infectious and Tropical Diseases, Foundation IRCCS San Matteo University of Pavia, Italy
	Title:Renal issues in HIV infected patients Dr. Mohamed G. Atta, Assistant Professor of Medicine, Johns Hopkins University School of Medicine, USA
	Title: Comparison of ARV service models in rural South Africa Dr. Helmuth Reuter, Ukwanda Centre for Rural Health, University of Stellenbosch, South Africa
No Photo	Title: An Oral Health Program for HIV/AIDS Patients and Orphans in a Developing Country Dr. Elaine Blignaut, Faculty of Dentistry, University of Limpopo, South Africa
	Title: HIV Vaccine Trial and HIV Treatment /Complications in a Caribbean Island Prof. Courtenay Bartholome, Director of Medical Research Foundation of Trinidad and Tobago
	Title: SR-01 HIV care for pregnant women at Siriraj Hospital, Bangkok, Thailand Dr. Anuvat Roongpisuthipong, Department of OB-GYN, Siriraj Hospital, Mahidol University, Thailand
	Title: New strategies for HIV-1 therapeutic intervention Dr. Anders Vahlne, Professor & Head, Division of Clinical Virology, Karolinska Institutet, Sweden
	Title: Human Immunodeficiency Virus Infection and Cardiovascular Diseases Dr. Adnan I. Qureshi, Director, Cerebrovascular Program, Zeenat Qureshi Stroke Research Center, USA

(Note: Due to some technical problems, we have not got all the photoes of our speakers, if your picuture is not on our website, you may send one of your favorite picture to Emily by email: emily@whts.org we apologise for any inconvenience caused. )